Back to Trades
Del Carmen Jeffrey
Chief Commercial OfficerCIK 0001816477
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Del Carmen Jeffrey, Chief Commercial Officer, has disclosed $14.9M in transactions — all concentrated in CATALYST PHARMACEUTICALS, INC. (CPRX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $256.2K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 17 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey | Chief Commercial Officer | Disposed | $12.1M |
| Dec 30 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey | Chief Commercial Officer | Exercise | $0 |
| Dec 10 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey | Chief Commercial Officer | Exercise | $0 |
| Nov 28 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey | Chief Commercial Officer | Sell | $256.2K |
| Nov 24 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey | Chief Commercial Officer | Exercise | $2.4M |
5 filings